George Gould joins BioSpecifics board
This article was originally published in Scrip
BioSpecifics Technologies, a biopharmaceutical company developing first-in-class collagenase-based products, has elected George Gould, an attorney, to its board of directors. Mr Gould is principal of George M. Gould, LLC, and of counsel to Gibbons PC. He has expertise in pharmaceutical and biotechnology intellectual property law, and was notably vice-president of licensing and corporate development and chief patent counsel at Roche for 28 years.